KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,170,000 | +79.2% | 344,038 | +98.1% | 0.00% | 0.0% |
| Q2 2018 | $653,000 | -2.7% | 173,707 | +5.9% | 0.00% | 0.0% |
| Q1 2018 | $671,000 | -12.1% | 164,003 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $763,000 | -28.5% | 164,003 | +9.1% | 0.00% | 0.0% |
| Q3 2017 | $1,067,000 | +0.9% | 150,327 | +2.8% | 0.00% | 0.0% |
| Q2 2017 | $1,057,000 | +23.6% | 146,228 | +5.3% | 0.00% | 0.0% |
| Q1 2017 | $855,000 | +5.0% | 138,874 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $814,000 | +14.0% | 138,874 | +3.3% | 0.00% | 0.0% |
| Q3 2016 | $714,000 | -19.8% | 134,472 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $890,000 | +11.7% | 134,472 | -21.2% | 0.00% | +100.0% |
| Q1 2016 | $797,000 | -7.5% | 170,693 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $862,000 | +59.9% | 170,693 | +11.5% | 0.00% | +100.0% |
| Q3 2015 | $539,000 | -64.7% | 153,125 | 0.0% | 0.00% | -66.7% |
| Q2 2015 | $1,528,000 | -14.8% | 153,125 | +8.7% | 0.00% | 0.0% |
| Q1 2015 | $1,793,000 | +0.6% | 140,816 | +11.8% | 0.00% | 0.0% |
| Q4 2014 | $1,783,000 | +1.4% | 125,993 | -1.5% | 0.00% | -25.0% |
| Q3 2014 | $1,758,000 | -10.6% | 127,866 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,967,000 | -13.2% | 127,866 | -3.9% | 0.00% | -20.0% |
| Q1 2014 | $2,266,000 | +49.7% | 133,007 | +13.8% | 0.01% | +66.7% |
| Q4 2013 | $1,514,000 | +33.2% | 116,887 | +3.8% | 0.00% | 0.0% |
| Q3 2013 | $1,137,000 | +38.7% | 112,567 | +2.6% | 0.00% | +50.0% |
| Q2 2013 | $820,000 | – | 109,764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |